文献速递流行病学与生物统计临床试验与 GCP

早期疗效检测:累积Meta分析揭示低分子肝素对癌症患者生存获益随时间消失

Early detection of the existence or absence of the treatment effect: A cumulative meta-analysis.
PubMed 文献 · J Clin Epidemiol · 2020-04-13

早期试验显示生存显著改善,但随时间推移获益逐渐消退,最终累积HR为0.98(95%CI 0.93;1.03),提示早期阳性结果可能源于事后亚组分析的p-hacking和选择性报告。

要点

  • 低分子肝素对癌症患者的总生存获益在累积Meta分析中随时间逐渐消失。
  • 最终累积HR为0.98(95%CI 0.93;1.03),提示无显著生存影响。
  • 早期阳性结果可能源于事后亚组分析的p-hacking和选择性报告。

核心结论

  • 尽管有实验数据支持和早期临床发现,低分子肝素对癌症患者的潜在抗肿瘤效应随时间推移逐渐消失,最终对总生存无影响。
  • 该结果提示早期研究中对事后亚组分析阳性结果可能存在p-hacking和选择性报告。

研究设计与样本

  • 研究设计为累积Meta分析,检索医学数据库纳入比较低分子肝素与安慰剂/无治疗(无静脉血栓栓塞患者)或维生素K拮抗剂(急性静脉血栓栓塞患者)的随机对照试验,评估总生存。
  • 按时间顺序每纳入一项研究后估计累积风险比(HR)。

主要发现

  • 早期试验的累积Meta分析显示低分子肝素显著改善总生存。
  • 这种表观获益随时间逐渐消退,趋向于低分子肝素对生存无效应。
  • 最终累积HR为0.98(95%CI 0.93;1.03)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: An unexpected promising effect of low molecular weight heparins (LMWHs) on survival in patients with cancer was observed in early trials in post hoc subgroup analyses but not found in more recent trials. To highlight a possible regression over time toward the lack of the antitumoral effect of LMWHs, we performed a cumulative meta-analysis of survival data from randomized controlled trials (RCTs). STUDY DESIGN AND SETTING: Medical databases were searched to identify RCTs comparing, in patients with cancer, LMWHs with placebo or no treatment in patients free of venous thromboembolism (VTE), or to vitamin K antagonists in patients who experienced an acute VTE in overall survival. The cumulative hazard ratio (HR) was estimated after each study inclusion in chronological order. RESULTS: Twenty-three studies (12,970 patients) were included. The cumulative meta-analysis of the earlier trials showed a significant improvement in overall survival with LMWHs. This apparent benefit then gradually regressed over time toward an absence of the effect of LMWHs on survival (HR: 0.98 [95% confidence interval, 0.93; 1.03]). CONCLUSION: Despite supportive experimental data and early clinical findings, the promising antitumoral effect of LMWHs in patients with cancer gradually vanished over time toward a lack of impact on overall survival. This result suggests 'p-hacking' and selective reporting of the positive results from post hoc subgroup analyses in the early studies.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Laporte S, Chapelle C, Trone JC, et al. Early detection of the existence or absence of the treatment effect: A cumulative meta-analysis. J Clin Epidemiol. 2020. PMID: 32298778. doi:10.1016/j.jclinepi.2020.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。